ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014

Oncology Nursing Society Small Grants Available

July 19, 1996

NCI-Approved Clinical Trials

July 25, 2003

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996